A Trial of PF-07901800 (TTI-621) for Patients With Hematologic Malignancies and Selected Solid Tumors
Pfizer
Pfizer
Celgene
GlaxoSmithKline
University of Wisconsin, Madison
AbbVie
Rutgers, The State University of New Jersey
Case Comprehensive Cancer Center